200 related articles for article (PubMed ID: 33531372)
1. Premalignant Oligodendrocyte Precursor Cells Stall in a Heterogeneous State of Replication Stress Prior to Gliomagenesis.
Sutcliffe MD; Galvao RP; Wang L; Kim J; Rosenfeld LK; Singh S; Zong H; Janes KA
Cancer Res; 2021 Apr; 81(7):1868-1882. PubMed ID: 33531372
[TBL] [Abstract][Full Text] [Related]
2. Transformation of quiescent adult oligodendrocyte precursor cells into malignant glioma through a multistep reactivation process.
Galvao RP; Kasina A; McNeill RS; Harbin JE; Foreman O; Verhaak RG; Nishiyama A; Miller CR; Zong H
Proc Natl Acad Sci U S A; 2014 Oct; 111(40):E4214-23. PubMed ID: 25246577
[TBL] [Abstract][Full Text] [Related]
3. p53 and NF 1 loss plays distinct but complementary roles in glioma initiation and progression.
Gonzalez PP; Kim J; Galvao RP; Cruickshanks N; Abounader R; Zong H
Glia; 2018 May; 66(5):999-1015. PubMed ID: 29392777
[TBL] [Abstract][Full Text] [Related]
4. The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.
Solga AC; Toonen JA; Pan Y; Cimino PJ; Ma Y; Castillon GA; Gianino SM; Ellisman MH; Lee DY; Gutmann DH
Oncotarget; 2017 Jul; 8(29):47206-47215. PubMed ID: 28525381
[TBL] [Abstract][Full Text] [Related]
5. Olig1/2-Expressing Intermediate Lineage Progenitors Are Predisposed to PTEN/p53-Loss-Induced Gliomagenesis and Harbor Specific Therapeutic Vulnerabilities.
Verma R; Chen X; Xin D; Luo Z; Ogurek S; Xin M; Rao R; Berry K; Lu QR
Cancer Res; 2023 Mar; 83(6):890-905. PubMed ID: 36634201
[TBL] [Abstract][Full Text] [Related]
6. Glial progenitors as targets for transformation in glioma.
Ilkhanizadeh S; Lau J; Huang M; Foster DJ; Wong R; Frantz A; Wang S; Weiss WA; Persson AI
Adv Cancer Res; 2014; 121():1-65. PubMed ID: 24889528
[TBL] [Abstract][Full Text] [Related]
7. Primitive Oligodendrocyte Precursor Cells Are Highly Susceptible to Gliomagenic Transformation.
Zamler DB; Hu J
Cancer Res; 2023 Mar; 83(6):807-808. PubMed ID: 36919423
[TBL] [Abstract][Full Text] [Related]
8. Mosaic analysis with double markers reveals tumor cell of origin in glioma.
Liu C; Sage JC; Miller MR; Verhaak RG; Hippenmeyer S; Vogel H; Foreman O; Bronson RT; Nishiyama A; Luo L; Zong H
Cell; 2011 Jul; 146(2):209-21. PubMed ID: 21737130
[TBL] [Abstract][Full Text] [Related]
9. Chd7 Collaborates with Sox2 to Regulate Activation of Oligodendrocyte Precursor Cells after Spinal Cord Injury.
Doi T; Ogata T; Yamauchi J; Sawada Y; Tanaka S; Nagao M
J Neurosci; 2017 Oct; 37(43):10290-10309. PubMed ID: 28931573
[TBL] [Abstract][Full Text] [Related]
10. Oligodendrocyte progenitor cell-specific delivery of lipid nanoparticles loaded with Olig2 synthetically modified messenger RNA for ischemic stroke therapy.
Xu J; Wang R; Luo W; Mao X; Gao H; Feng X; Chen G; Yang Z; Deng W; Nie Y
Acta Biomater; 2024 Jan; 174():297-313. PubMed ID: 38096960
[TBL] [Abstract][Full Text] [Related]
11. Single-Cell Transcriptomics Uncovers Glial Progenitor Diversity and Cell Fate Determinants during Development and Gliomagenesis.
Weng Q; Wang J; Wang J; He D; Cheng Z; Zhang F; Verma R; Xu L; Dong X; Liao Y; He X; Potter A; Zhang L; Zhao C; Xin M; Zhou Q; Aronow BJ; Blackshear PJ; Rich JN; He Q; Zhou W; Suvà ML; Waclaw RR; Potter SS; Yu G; Lu QR
Cell Stem Cell; 2019 May; 24(5):707-723.e8. PubMed ID: 30982771
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic signaling is dominant to cell of origin and dictates astrocytic or oligodendroglial tumor development from oligodendrocyte precursor cells.
Lindberg N; Jiang Y; Xie Y; Bolouri H; Kastemar M; Olofsson T; Holland EC; Uhrbom L
J Neurosci; 2014 Oct; 34(44):14644-51. PubMed ID: 25355217
[TBL] [Abstract][Full Text] [Related]
13. White Matter Stroke Induces a Unique Oligo-Astrocyte Niche That Inhibits Recovery.
Sozmen EG; DiTullio DJ; Rosenzweig S; Hinman JD; Bridges SP; Marin MA; Kawaguchi R; Coppola G; Carmichael ST
J Neurosci; 2019 Nov; 39(47):9343-9359. PubMed ID: 31591156
[TBL] [Abstract][Full Text] [Related]
14. MADM gives new insights into gliomagenesis.
Lei L; Canoll P
J Mol Cell Biol; 2011 Oct; 3(5):273-5. PubMed ID: 21926086
[TBL] [Abstract][Full Text] [Related]
15. A novel mouse model of diffuse midline glioma initiated in neonatal oligodendrocyte progenitor cells highlights cell-of-origin dependent effects of H3K27M.
Tomita Y; Shimazu Y; Somasundaram A; Tanaka Y; Takata N; Ishi Y; Gadd S; Hashizume R; Angione A; Pinero G; Hambardzumyan D; Brat DJ; Hoeman CM; Becher OJ
Glia; 2022 Sep; 70(9):1681-1698. PubMed ID: 35524725
[TBL] [Abstract][Full Text] [Related]
16. In Vivo Clonal Analysis Reveals Development Heterogeneity of Oligodendrocyte Precursor Cells Derived from Distinct Germinal Zones.
Liu R; Jia Y; Guo P; Jiang W; Bai R; Liu C
Adv Sci (Weinh); 2021 Oct; 8(20):e2102274. PubMed ID: 34396711
[TBL] [Abstract][Full Text] [Related]
17. Double minute amplification of mutant PDGF receptor α in a mouse glioma model.
Zou H; Feng R; Huang Y; Tripodi J; Najfeld V; Tsankova NM; Jahanshahi M; Olson LE; Soriano P; Friedel RH
Sci Rep; 2015 Feb; 5():8468. PubMed ID: 25683249
[TBL] [Abstract][Full Text] [Related]
18. Candidate pathways for promoting differentiation or quiescence of oligodendrocyte progenitor-like cells in glioma.
Dougherty JD; Fomchenko EI; Akuffo AA; Schmidt E; Helmy KY; Bazzoli E; Brennan CW; Holland EC; Milosevic A
Cancer Res; 2012 Sep; 72(18):4856-68. PubMed ID: 22865458
[TBL] [Abstract][Full Text] [Related]
19. Brief review: Can modulating DNA methylation state help the clinical application of oligodendrocyte precursor cells as a source of stem cell therapy?
Egawa N; Chung KK; Takahashi R; Lo EH; Inoue H; Arai K
Brain Res; 2019 Nov; 1723():146386. PubMed ID: 31419426
[TBL] [Abstract][Full Text] [Related]
20. Stalled oligodendrocyte differentiation in IDH-mutant gliomas.
Wei Y; Li G; Feng J; Wu F; Zhao Z; Bao Z; Zhang W; Su X; Li J; Qi X; Duan Z; Zhang Y; Vega SF; Jakola AS; Sun Y; Carén H; Jiang T; Fan X
Genome Med; 2023 Apr; 15(1):24. PubMed ID: 37055795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
